Chronic hepatitis, not elsewhere classified

K11_CHRONHEP

hepatitis B virus infection: A viral infection caused by the hepatitis B virus.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K73 Hospital discharge: ICD-9 — 5714A\|5714X Hospital discharge: ICD-8 — 57001 Cause of death: ICD-10 — K73 Cause of death: ICD-9 — 5714A\|5714X Cause of death: ICD-8 — 57001 2 out of 7 registries used, show all original rules.	1256
4. Check minimum number of events None	1256
5. Include endpoints None	1256
6. Filter based on genotype QC (FinnGen only)	1256

Control definitions (FinnGen only)

Control exclude: K11_LIVER

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K70-K77
Name in latin: Hepatitis chronica non alibi classificata

NAME	K11_CHRONHEP
CONTROL_EXCLUDE	K11_LIVER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K73
HD_ICD_9	5714A\|5714X
HD_ICD_8	57001
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K73
COD_ICD_9	5714A\|5714X
COD_ICD_8	57001
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Chronic hepatitis, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	7890	4726	3100
Only index persons	6673	4123	2550
Unadjusted period prevalence (%)
Whole population	0.12	0.14	0.09
Only index persons	0.13	0.15	0.10
Median age at first event (years)
Whole population	55.74	57.47	53.03
Only index persons	54.41	56.19	51.54

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1256	812	444
Unadjusted period prevalence (%)	0.25	0.28	0.20
Median age at first event (years)	54.57	54.18	55.27

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1128: Matched controls
11277

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

+∞

323.0

505

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

142.4

323.0

438

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

+∞

323.0

397

L04AX01

ATC

azathioprine; systemic

34.6

308.9

411

184

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

575.0

241.0

231

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

13.9

218.8

413

451

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

+∞

210.1

195

K76.9

ICD-10 Finland

Liver disease, unspecified

588.0

203.6

196

A05AA02

ATC

ursodeoxycholic acid; oral

64.0

195.5

226

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

9.6

182.3

426

670

K75.4

ICD-10 Finland

Autoimmune hepatitis

+∞

171.3

160

A07EA06

ATC

budesonide; oral, local oral

21.6

163.1

247

144

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

63.6

157.1

182

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

+∞

136.3

128

K74.3

ICD-10 Finland

Primary biliary cirrhosis

+∞

135.2

127

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

+∞

122.1

115

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.7

118.8

566

2006

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

34.1

101.4

133

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

5.6

95.4

324

763

K83.0

ICD-10 Finland

Cholangitis

30.9

83.5

112

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

59.4

79.4

H02AB06

ATC

prednisolone; systemic

3.3

78.2

699

3732

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.4

78.1

555

2499

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

109.0

75.0

Z94.4

ICD-10 Finland

Liver transplant status

363.6

69.4

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

240.9

67.0

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

15.1

65.3

111

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

26.0

63.5

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

169.4

61.6

JJC00

NOMESCO Finland

Allogenic transplantation of liver

608.7

59.3

L01BB02

ATC

mercaptopurine; oral

29.8

57.8

L04AA06

ATC

mycophenolic acid; systemic

16.4

55.6

UJF30

NOMESCO Finland

Ileoscopy through colon

4.7

54.3

206

516

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

19.0

51.8

C03DA01

ATC

spironolactone; oral

4.5

50.1

195

499

5714X

ICD-9 Finland

Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ALIA SEU NUD]

+∞

49.3

UJF32

NOMESCO Finland

Coloscopy

2.8

46.6

390

1794

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

66.6

44.5

K51.5

ICD-10 Finland

Left sided colitis

9.5

43.9

106

L04AD01

ATC

ciclosporin; systemic

11.3

43.1

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

11.3

43.1

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

422.3

41.4

K73.89

ICD-10 Finland

Other long-term hepatitis, not classified differently

+∞

40.9

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

6.0

40.6

118

216

H02AB07

ATC

prednisone; oral

3.3

40.5

240

864

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

411.5

40.4

A02BC02

ATC

pantoprazole; systemic

2.4

39.7

802

5712

A07EC02

ATC

mesalazine; oral, rectal

5.1

39.3

132

286

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

207.1

39.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

39.0

543

3215

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.4

38.9

151

381

127

Kela drug reimbursment

Transplant complication

13.3

38.5

R94.5

ICD-10 Finland

Abnormal results of liver function studies

20.6

38.2

R18

ICD-10 Finland

Ascites

14.8

37.3

K72.9

ICD-10 Finland

Hepatic failure, unspecified

196.4

37.0

ZX120

NOMESCO Finland

Intravenous

3.6

36.0

178

555

C03CA01

ATC

furosemide; systemic

2.6

35.6

334

1594

N02AX02

ATC

tramadol; systemic, rectal

2.2

35.4

540

3284

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

19.8

35.1

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

22.7

34.6

K74.0

ICD-10 Finland

Hepatic fibrosis

+∞

33.5

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

6.5

33.3

149

JJA20

NOMESCO Finland

Open biopsy of liver

90.3

31.9

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.5

30.7

291

1381

J01MA02

ATC

ciprofloxacin; systemic

2.1

30.5

480

2899

D97

ICPC

Liver disease NOS

39.3

30.4

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

30.3

286

1351

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

10.0

29.7

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

106.2

28.8

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

153.9

28.8

103

Kela drug reimbursment

Diabetes, insulin-treated

2.3

28.7

320

1641

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.4

28.7

306

1535

JJ5AT

NOMESCO Finland

288.3

27.9

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.9

27.6

122

344

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

27.6

445

2687

UJK02

NOMESCO Finland

ERCP

8.6

26.3

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

11.6

26.3

K73.8

ICD-10 Finland

Other chronic hepatitis, not elsewhere classified

+∞

26.1

A10AE04

ATC

insulin glargine; parenteral

3.3

26.1

140

461

C10AC01

ATC

colestyramine; oral

6.6

25.5

107

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.7

25.4

118

347

A06AD11

ATC

lactulose; oral

2.7

25.2

189

777

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.9

24.8

169

652

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

9.6

23.4

T90

ICPC

Diabetes non-insulin dependent

2.2

23.3

276

1434

K72.1

ICD-10 Finland

Chronic hepatic failure

+∞

23.0

A07AA11

ATC

rifaximin; oral

+∞

23.0

H02AB04

ATC

methylprednisolone; systemic

2.4

21.2

207

977

R50.9

ICD-10 Finland

Fever, unspecified

2.5

20.8

182

811

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

78.3

20.7

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

20.3

157

652

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

48.9

20.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.5

19.9

171

753

5714B

ICD-9 Finland

Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ACTIVA (HBSAG-)]

+∞

19.8

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

106.9

19.6

K50.8

ICD-10 Finland

Other Crohn disease

7.6

19.3

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

10.6

19.2

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

19.0

268

1486

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.7

19.0

148

A10BA02

ATC

metformin; oral

2.0

19.0

301

1746

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

18.9

207

1027

J01MA12

ATC

levofloxacin; systemic

2.2

18.8

223

1147

K70.1

ICD-10 Finland

Alcoholic hepatitis

+∞

18.8

UJK12

NOMESCO Finland

Peroral cholangioscopy

28.4

18.8

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.6

18.7

150

634

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

18.3

177

828

K50.1

ICD-10 Finland

Crohn disease of large intestine

10.6

18.2

JN3AD

NOMESCO Finland

Abdominal CT examination

3.2

18.2

102

344

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

+∞

17.7

K76.89

ICD-10 Finland

Other specified diseases of liver

96.6

17.6

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.3

17.4

293

L04AA01

ATC

[U] ciclosporin; systemic

7.1

17.3

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.2

17.2

105

A10BH01

ATC

sitagliptin; oral

2.7

17.1

122

482

B18.2

ICD-10 Finland

Chronic viral hepatitis C

10.9

17.0

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.9

17.0

186

K92.0

ICD-10 Finland

Haematemesis

6.3

16.9

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.6

16.9

228

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

16.8

133

556

UJD02

NOMESCO Finland

Gastroscopy

3.6

16.8

229

K75.2

ICD-10 Finland

Nonspecific reactive hepatitis

+∞

16.7

D64.9

ICD-10 Finland

Anaemia, unspecified

2.7

16.6

123

496

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.6

15.9

124

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.7

15.8

115

459

K70.4

ICD-10 Finland

Alcoholic hepatic failure

+∞

15.7

K70.0

ICD-10 Finland

Alcoholic fatty liver

162.1

15.5

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

7.8

15.4

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

7.5

15.0

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

10.2

15.0

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

12.6

14.9

K75.8

ICD-10 Finland

Other specified inflammatory liver diseases

+∞

14.6

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

+∞

14.6

5719X

ICD-9 Finland

Chronic liver disease and cirrhosis, Unspecified chronic liver disease without mention of alcohol

+∞

14.6

K73.1

ICD-10 Finland

Chronic lobular hepatitis, not elsewhere classified

+∞

14.6

B19.9

ICD-10 Finland

Unspecified viral hepatitis without hepatic coma

151.9

14.5

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

7.0

14.5

K51.8

ICD-10 Finland

Other ulcerative colitis

7.0

14.5

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.1

14.4

280

E66.00

ICD-10 Finland

Metabolic syndrome

3.2

14.4

247

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

14.4

192

1030

A02BC03

ATC

lansoprazole; oral

1.8

14.3

330

2148

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

14.2

305

1942

A02BC01

ATC

omeprazole; systemic

1.8

14.1

301

1911

C07AA05

ATC

propranolol; systemic

1.9

14.1

236

1382

SPAT1262

SPAT

Handing over of treatment supplies

2.0

14.0

208

1164

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

13.7

578

4439

P01BA02

ATC

hydroxychloroquine; oral

2.5

13.7

111

470

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

10.6

13.3

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.7

13.2

358

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

13.1

188

1035

H02AB09

ATC

hydrocortisone; systemic

4.7

13.1

TK800

NOMESCO Finland

Hemodialysis

5.0

13.0

A10BG03

ATC

pioglitazone; oral

4.6

13.0

102

K50.0

ICD-10 Finland

Crohn disease of small intestine

6.7

12.8

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.3

12.7

119

546

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

12.7

208

K83.1

ICD-10 Finland

Obstruction of bile duct

7.9

12.6

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

9.4

12.5

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

12.5

123

577

XW000

NOMESCO Finland

Bone marrow biopsy

3.4

12.4

184

K50.9

ICD-10 Finland

Crohn disease, unspecified

6.3

12.3

160

Kela drug reimbursment

exenatide

4.8

12.3

E66.8

ICD-10 Finland

Other obesity

2.9

12.3

282

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

12.3

111

499

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

5.0

12.1

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

27.0

12.1

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

13.5

12.0

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

12.0

247

1540

P01AB01

ATC

metronidazole; oral, rectal

1.6

11.8

440

3232

WX402

NOMESCO Finland

General anaesthesia

1.9

11.7

195

1129

57300

ICD-8 Finland

Other diseases of liver, Hepatitis NUD

+∞

11.5

K76.7

ICD-10 Finland

Hepatorenal syndrome

+∞

11.5

5739X

ICD-9 Finland

Other disorders of liver, Unspecified disorder of liver

121.2

11.4

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

5.5

11.4

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.1

11.4

208

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

11.3

141

733

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.6

11.3

148

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

9.0

11.3

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

25.3

11.2

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

25.3

11.2

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

11.1

282

1865

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

11.1

318

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

10.9

170

961

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

10.9

213

WW500

NOMESCO Finland

Blood transfusion

3.3

10.9

175

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

12.1

10.9

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

10.8

225

1401

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

10.7

10.8

UJF92

NOMESCO Finland

Capsular endoscopy

4.2

10.5

57309

ICD-8 Finland

Other diseases of liver, Unspecified

+∞

10.4

A10AE05

ATC

insulin detemir; parenteral

2.8

10.4

251

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

7.0

10.1

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

10.1

395

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

10.1

190

1144

H26.3

ICD-10 Finland

Drug-induced cataract

8.5

10.1

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

9.9

204

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.3

9.9

400

A10BH05

ATC

linagliptin; oral

3.1

9.9

182

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

9.8

143

786

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

9.8

136

737

H03AA01

ATC

levothyroxine sodium; systemic

1.6

9.8

260

1734

A10BJ06

ATC

semaglutide; parenteral

3.3

9.7

151

A02BA02

ATC

ranitidine; systemic

1.7

9.7

204

1274

K29.6

ICD-10 Finland

Other gastritis

6.4

9.6

M05BA04

ATC

alendronic acid; oral

2.2

9.6

455

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.8

9.5

106

N02AA05

ATC

oxycodone; systemic

1.9

9.4

149

845

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

7.6

9.4

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

100.8

9.4

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

+∞

9.4

K75.3

ICD-10 Finland

Granulomatous hepatitis, not elsewhere classified

+∞

9.4

K74.2

ICD-10 Finland

Hepatic fibrosis with hepatic sclerosis

+∞

9.4

K71.2

ICD-10 Finland

Toxic liver disease with acute hepatitis

+∞

9.4

E0000UV

ATC

1.5

9.4

420

3178

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.8

9.2

203

WX892

NOMESCO Finland

Monitored bed care

2.3

9.2

371

A07EA02

ATC

hydrocortisone; rectal

3.9

9.2

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

9.1

128

699

N06AB04

ATC

citalopram; systemic

1.7

9.0

228

1499

C08CA01

ATC

amlodipine; oral

1.5

9.0

338

2452

C07AB07

ATC

bisoprolol; oral

1.5

8.7

444

3436

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

50.4

8.7

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

50.4

8.7

K92.1

ICD-10 Finland

Melaena

2.6

8.7

246

AA1AD

NOMESCO Finland

CT of head and brain

1.6

8.6

224

1478

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

3.8

8.6

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

27.7

8.5

7904A

ICD-9 Finland

Nonspecific findings on examination of blood, Nonspecific elevation oflevels of transaminase or lactic acid dehydrogenase [LDH]

90.7

8.4

E66.9

ICD-10 Finland

Obesity, unspecified

2.9

8.4

173

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

4.9

8.4

WX872

NOMESCO Finland

Intensive care

2.7

8.4

221

5714A

ICD-9 Finland

Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA PERSISTENS]

+∞

8.3

K71.9

ICD-10 Finland

Toxic liver disease, unspecified

+∞

8.3

K29.7

ICD-10 Finland

Gastritis, unspecified

2.9

8.3

169

WX002

NOMESCO Finland

Sedation and analgesia

1.6

8.2

210

1377

J01FF01

ATC

clindamycin; systemic

1.5

8.1

282

1999

E83.1

ICD-10 Finland

Disorders of iron metabolism

11.8

8.1

3AC01

NOMESCO Finland

6.9

8.1

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

22.2

8.0

S97

ICPC

Chronic ulcer skin

2.5

8.0

241

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.1

8.0

134

C07AG02

ATC

carvedilol; oral

2.5

8.0

252

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

7.3

8.0

N05CF01

ATC

zopiclone; oral

1.5

7.9

317

2322

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

7.8

7.9

N03AX16

ATC

pregabalin; oral

1.6

7.9

239

1640

N30.0

ICD-10 Finland

Acute cystitis

1.8

7.9

150

907

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.8

7.9

170

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

7.8

532

4335

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

7.8

127

728

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.1

7.8

453

K51

ICD-10 Finland

Ulcerative colitis

7.0

7.8

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.5

7.7

251

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

7.7

349

2621

A10BJ02

ATC

liraglutide; parenteral

3.5

7.6

100

RS120

NOMESCO Finland

18.5

7.6

M35.1

ICD-10 Finland

Other overlap syndromes

11.9

7.6

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

7.5

105

571

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

7.5

158

982

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

7.5

289

2094

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

7.5

293

2133

A46

ICD-10 Finland

Erysipelas

1.8

7.4

132

779

JN4BD

NOMESCO Finland

Extensive body CT

1.9

7.4

111

621

J01DB01

ATC

cefalexin; oral

1.5

7.4

878

7918

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

7.3

257

K76.6

ICD-10 Finland

Portal hypertension

+∞

7.3

K75.0

ICD-10 Finland

Abscess of liver

+∞

7.3

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

9.4

7.3

K81.9

ICD-10 Finland

Cholecystitis, unspecified

5.2

7.3

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

7.3

348

Z94.0

ICD-10 Finland

Kidney transplant status

5.8

7.2

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

4.7

7.2

L04AB04

ATC

adalimumab; parenteral

3.7

7.2

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

7.2

391

A10BX04

ATC

[U] exenatide; parenteral

5.1

7.1

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.7

7.1

182

R4110

NOMESCO Finland

Physiotherapy

1.5

7.1

274

1986

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.2

7.0

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.9

7.0

K90.0

ICD-10 Finland

Coeliac disease

2.9

7.0

140

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.4

7.0

253

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

6.9

475

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.6

6.9

197

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.6

6.9

179

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

6.7

6.8

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.6

6.8

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

6.8

134

818

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

40.3

6.8

L04AA05

ATC

[U] tacrolimus; systemic

40.3

6.8

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

16.8

6.7

RS220

NOMESCO Finland

4.1

6.7

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.1

6.7

R53

ICD-10 Finland

Malaise and fatigue

1.6

6.7

199

1357

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

6.7

245

1750

JN4CD

NOMESCO Finland

Very extensive body CT

2.7

6.7

163

205

Kela drug reimbursment

Chronic hypertension

1.5

6.6

239

1700

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

6.5

6.6

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

12.3

6.6

A41.8

ICD-10 Finland

Other specified sepsis

4.4

6.6

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.9

6.5

136

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.7

6.5

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

6.5

185

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

6.2

6.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

6.5

126

767

R03AC02

ATC

salbutamol; inhalant

1.4

6.5

535

4459

N17.8

ICD-10 Finland

Other acute renal failure

5.4

6.5

A07AA09

ATC

vancomycin; oral

4.3

6.4

R06.0

ICD-10 Finland

Dyspnoea

1.5

6.4

234

1669

SPAT1255

SPAT

Intravenous administration of medicine

2.1

6.4

324

198

Kela drug reimbursment

Sorafenib

70.2

6.4

0705A

ICD-9 Finland

Viral hepatitis, Other specified viral hepatitis without mention of hepatic coma

70.2

6.4

N06AX11

ATC

mirtazapine; oral

1.4

6.4

310

2344

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

6.4

418

A10BK03

ATC

empagliflozin; oral

2.0

6.4

363

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

6.4

241

1732

J01DA01

ATC

[U] cefalexin; systemic

1.4

6.3

645

5559

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

6.3

426

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

6.3

140

882

WX882

NOMESCO Finland

High dependency care

3.2

6.3

100

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

6.3

458

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

18.1

6.3

57308

ICD-8 Finland

Other diseases of liver, Alii definiti

+∞

6.3

57001

ICD-8 Finland

Acute and subacute necrosis of liver, Hepatitis subacuta degenerativa

+∞

6.3

UKC02

NOMESCO Finland

Cystoscopy

1.7

6.2

138

870

1280

FHL

Endoscopic retrograde cholangiography and pancreaticography

26.8

6.2

6611

FHL

Needle biopsy in the operating room

26.8

6.2

M81.8

ICD-10 Finland

Other osteoporosis

7.1

6.2

A10BX07

ATC

[U] liraglutide; parenteral

4.1

6.2

M10.9

ICD-10 Finland

Gout, unspecified

2.3

6.2

234

J05AB11

ATC

valaciclovir; oral

1.7

6.2

136

854

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

6.2

498

A10AB06

ATC

insulin glulisine; parenteral

5.4

6.2

R11

ICD-10 Finland

Nausea and vomiting

2.0

6.1

396

L28

ICPC

Limited function/disability (L)

1.6

6.1

143

913

A10BK01

ATC

dapagliflozin; oral

2.5

6.1

191

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

218

30.11

318.93

1.2

1.1

g/l

1.6

1.5

1.29

194

(3007566) Smooth muscle Ab [Titer] in Serum

496

185

43.66

307.65

1.8

1.1

titre

317.4

83.5

2.79

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

665

824

16.03

307.65

5.8

2.0

g/l

0.2

2.51

627

782

(3028026) IgM [Mass/volume] in Serum or Plasma

534

536

16.59

307.65

2.0

1.8

g/l

1.5

0.04

494

492

(3005719) IgG [Mass/volume] in Serum or Plasma

708

693

22.12

307.65

7.4

2.9

g/l

12.4

10.3

17.71

675

632

(40768441) Liver Pathology biopsy report

327

102.46

307.65

1.8

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

533

1090

7.76

273.49

7.3

2.5

umol/l

15.5

7.3

5.24

492

936

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

939

3321

8.24

272.60

11.2

3.0

u/l

48.1

30.5

19.88

913

3160

(3037522) Nuclear Ab [Titer] in Serum

586

1363

7.19

263.32

2.0

1.3

titre

794.3

520.4

2.67

210

285

(3024561) Albumin [Mass/volume] in Serum or Plasma

1030

4221

9.00

247.69

12.5

4.3

g/l

35.6

36.0

1.76

995

3918

(3006922) Hepatitis E virus Ab [Presence] in Serum

151

39.78

244.11

1.2

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

148

38.88

237.85

1.1

1.0

mg/l

281.6

309.3

1.22

129

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

144

36.84

228.01

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

144

36.84

228.01

1.2

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

483

1082

6.63

220.77

1.5

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

199

147

15.90

218.94

6.3

2.2

umol/l

40.4

30.5

3.42

184

117

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

504

1215

6.26

212.06

2.7

2.3

25.5

22.9

2.45

435

1036

(3004789) Transferrin [Mass/volume] in Serum or Plasma

521

1313

6.07

208.34

2.6

2.2

g/l

2.4

1.29

489

1222

(3016650) Hepatitis A virus Ab [Presence] in Serum

184

132

16.16

205.43

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1083

5242

8.74

198.91

17.6

5.7

umol/l

15.3

10.7

7.55

1063

4963

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

185

146

14.69

195.48

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

526

1440

5.56

188.94

2.7

2.3

umol/l

14.6

13.4

2.37

498

1326

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

139

23.20

187.31

1.5

1.1

titre

349.3

60.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

507

1431

5.26

173.61

1.5

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

164

132

14.14

170.78

2.0

1.7

g/l

0.7

0.9

0.53

124

(3033658) Prothrombin time (PT) actual/Normal

683

2506

4.78

166.64

12.4

3.5

91.1

93.1

1.23

667

2442

(3007164) IgA [Mass/volume] in Serum or Plasma

595

2018

4.70

159.54

2.1

1.4

g/l

3.0

2.2

12.35

482

1196

(3032080) INR in Blood by Coagulation assay

846

3820

4.72

152.45

13.5

7.6

inr

1.1

1.2

1.54

254

1100

(42870588) Differential panel, method unspecified - Blood

776

3391

4.37

143.58

12.5

5.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

163

186

9.92

133.58

6.4

5.7

iu/ml

1193.3

331.8

1.10

(3001604) Monocytes [#/volume] in Blood

950

5062

4.60

127.11

14.0

5.7

e9/l

0.6

1.05

875

4384

(3006315) Basophils [#/volume] in Blood

951

5082

4.59

126.44

14.1

5.7

e9/l

0.0

0.33

879

4409

(3013115) Eosinophils [#/volume] in Blood

960

5254

4.51

121.12

14.3

6.0

e9/l

0.2

1.68

889

4642

(3019198) Lymphocytes [#/volume] in Blood

954

5209

4.46

120.48

14.1

5.7

e9/l

1.7

1.9

7.94

882

4600

(3022096) Basophils/100 leukocytes in Blood

886

4604

4.14

120.05

14.4

5.9

0.7

2.76

866

4291

(3006504) Eosinophils/100 leukocytes in Blood

901

4752

4.17

119.04

14.3

5.8

2.9

0.05

878

4423

(3019069) Monocytes/100 leukocytes in Blood

902

4779

4.15

117.92

14.8

6.1

9.1

8.5

5.86

880

4472

(3018010) Neutrophils/100 leukocytes in Blood

901

4848

4.04

113.22

14.2

5.6

57.0

56.7

0.29

879

4534

(3002030) Lymphocytes/100 leukocytes in Blood

906

4917

4.02

111.80

14.6

5.9

28.1

28.4

0.51

882

4581

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

152

198

8.60

111.78

1.3

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

390

1231

4.14

109.11

2.3

1.8

1.6

1.4

3.37

340

1099

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

146

190

8.56

107.36

1.2

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

23.04

106.19

28.1

29.4

ug/l

6.6

7.2

0.82

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

145

190

8.50

105.99

1.3

1.2

u/ml

346.9

246.1

2.12

113

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

147

9.67

105.31

2.6

3.1

u/ml

955.4

2242.4

0.34

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

824

4318

3.64

104.61

3.7

2.2

nmol/l

74.6

77.3

2.07

771

3872

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

664

3118

3.40

99.19

4.9

2.4

u/l

59.8

56.1

0.83

632

2890

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

189

354

6.11

98.93

4.5

3.1

u/ml

356.9

3942.1

0.70

169

309

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

12.91

96.99

1.1

1.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

982

5957

3.97

94.97

17.3

8.9

e9/l

3.7

4.0

6.65

909

5223

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

132

177

8.22

94.42

1.2

1.4

u/ml

110.2

105.4

0.20

(44816559) Phosphatidylethanol [Mass/volume] in Blood

134

189

7.82

91.74

1.4

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

37.27

91.38

3.5

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1148

7958

6.15

87.90

25.0

7.0

u/l

100.3

76.4

31.43

1128

7474

(3018677) aPTT in Platelet poor plasma by Coagulation assay

400

1467

3.53

87.31

2.6

2.1

30.4

29.4

2.42

386

1422

(3048929) Epstein Barr virus Ab [Presence] in Serum

167

316

5.94

86.11

1.4

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

19.60

85.30

4.5

2.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

158

291

6.07

83.74

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1051

6960

4.13

82.44

10.5

2.8

u/l

119.3

44.5

30.86

1008

6503

(3010375) cycloSPORINE [Mass/volume] in Blood

17.36

79.33

33.0

30.4

ug/l

117.0

137.4

0.93

(3020779) Urea [Moles/volume] in Serum or Plasma

263

780

4.00

77.99

11.4

6.8

mmol/l

9.0

0.03

252

740

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

839

4947

3.10

77.67

9.2

6.5

mmol/l

1.2

0.45

726

4160

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

109

147

8.02

77.33

1.5

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

252

739

4.01

75.78

1.3

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

9.64

71.48

1.2

1.1

u/l

48.8

53.4

0.42

(4035726)

276

895

3.67

71.41

1.5

1.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

777

4519

2.89

71.39

7.5

5.8

mmol/l

1.2

0.61

732

4069

(3001122) Ferritin [Mass/volume] in Serum or Plasma

765

4435

2.85

70.33

3.8

2.7

ug/l

209.7

113.1

5.72

722

4103

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

110

167

7.12

70.17

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

138

269

5.64

68.53

4.8

3.3

mg/l

1.6

1.4

1.05

129

248

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

278

933

3.54

67.99

3.7

2.2

u/l

33.1

36.2

0.62

249

795

(3018418) pH of Serum or Plasma

572

2953

2.72

64.40

4.9

4.0

7.4

0.24

101

549

(3022217) INR in Platelet poor plasma by Coagulation assay

308

1138

3.26

64.23

14.2

22.5

inr

1.2

1.3

0.57

152

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

503

2438

2.77

64.08

2.9

2.1

mg/l

3.1

3.0

0.52

452

2077

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

285

1012

3.35

63.37

3.7

4.6

u/l

257.7

246.3

0.29

278

967

(3033799) Differential panel - Peritoneal fluid

32.57

63.20

3.4

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

488

2359

2.75

62.11

1.5

1.2

u/ml

1.3

1.7

0.46

116

633

(3001186) Copper [Moles/volume] in Serum or Plasma

34.63

58.04

1.8

1.1

umol/l

17.4

16.9

0.16

(3012095) Magnesium [Moles/volume] in Serum or Plasma

363

1595

2.79

54.52

4.5

3.2

mmol/l

0.8

3.70

344

1490

(3048689) Calprotectin [Mass/mass] in Stool

318

1304

2.93

54.36

3.7

2.2

ug/g

150.9

109.4

2.00

272

1023

(3013707) Erythrocyte sedimentation rate by Westergren method

1045

7663

3.16

53.47

8.4

4.0

mm/h

17.9

11.6

26.69

990

7083

(3009445) Proteinase 3 Ab [Units/volume] in Serum

153

401

4.21

52.83

1.9

1.5

u/ml

5.0

11.0

0.93

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

8.27

51.94

2.3

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

258

964

3.11

51.85

4.3

4.2

ug/l

3.0

19.2

2.09

213

786

(3003458) Phosphate [Moles/volume] in Serum or Plasma

302

1248

2.87

50.52

7.4

5.1

mmol/l

1.1

1.0

0.55

291

1152

(3042733) HLA Ab [Presence] in Serum

15.48

47.84

1.5

4.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

20.03

47.74

2.2

1.5

e6/l

4416.8

4704.1

0.03

(3013826) Glucose [Moles/volume] in Serum or Plasma

857

5847

2.47

47.73

8.4

4.6

mmol/l

7.1

6.6

5.03

828

5452

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

9.87

47.12

2.0

1.5

u/l

5.4

7.3

0.21

(4062490)

7.86

47.02

1.4

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

7.88

45.74

1.5

1.4

g/l

10.0

6.6

2.68

(3028192) IgG subclass 2 [Mass/volume] in Serum

7.88

45.74

1.5

1.4

g/l

3.2

2.5

1.42

(3024139) IgG subclass 3 [Mass/volume] in Serum

7.88

45.74

1.5

1.4

g/l

0.5

0.3

3.38

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

10.38

45.36

1.3

1.1

u/l

19.9

14.9

0.84

(3044640) Blood type and Crossmatch panel - Blood

555

3190

2.33

45.35

3.3

2.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

209

769

3.06

42.59

6.2

3.9

0.5

0.6

0.29

177

(3036481) Cortisol [Moles/volume] in Serum or Plasma

239

952

2.87

42.18

2.2

2.1

nmol/l

356.6

377.1

0.43

223

874

(3017181) Myelocytes/100 leukocytes in Blood

220

841

2.96

41.85

6.7

4.0

0.6

1.0

1.80

238

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

122

322

4.09

41.49

2.1

1.6

titre

233.3

166.7

—

(40758558) Short blood count panel - Blood

470

2622

2.27

40.09

11.9

6.7

—

(3021589) Normoblasts [#/volume] in Blood

697

4561

2.19

39.74

19.8

8.9

e9/l

0.0

0.89

610

3740

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

445

2436

2.28

39.64

3.3

2.2

—

(3023368) Bacteria identified in Blood by Culture

454

2540

2.23

38.05

6.2

4.0

—

(3042936) Bacteria identified in Isolate by Culture

300

1405

2.49

37.92

2.9

2.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

170

5.09

37.67

3.7

3.8

u/ml

43.6

2080.0

0.78

162

(3025159) Blasts/100 leukocytes in Blood

197

750

2.93

37.52

6.9

4.1

0.0

0.6

0.65

185

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

182

664

3.04

37.40

2.4

1.5

—

(3024932) HLA-DR beta [Type]

11.84

37.06

1.0

1.2

—

(3024471) HLA-A [Type]

11.49

36.36

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

130

396

3.55

35.85

2.0

g/l

1.2

1.5

3.71

117

349

(3044007) Cell count panel - Peritoneal fluid

14.90

35.74

2.7

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

232

1003

2.61

34.40

3.1

2.9

2.2

1.8

4.11

222

903

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

7.76

34.13

1.1

1.2

—

(40768797) Stomach Pathology biopsy report

300

1467

2.37

34.07

1.3

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

116

343

3.62

33.41

2.4

1.9

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

133

432

3.32

33.10

3.9

mmol/l

23.7

24.2

1.01

124

389

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

10.27

32.83

1.8

1.3

ug/l

10.6

8.5

1.45

(3021440) Promyelocytes/100 leukocytes in Blood

196

797

2.73

32.75

7.1

4.0

0.0

0.1

2.65

216

(3023520) Reticulocytes [#/volume] in Blood

185

735

2.78

32.31

2.8

e9/l

77.0

73.1

0.65

155

562

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

697

4825

2.00

31.16

5.4

3.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

223

4.12

30.66

1.5

1.2

u/ml

1.4

6.2

0.52

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

603

4033

1.95

29.11

2.4

1.9

pmol/l

97.4

96.0

0.25

323

2027

(3022145) Colonoscopy Study observation

243

1157

2.36

28.88

1.9

1.3

—

(3002032) Base excess in Venous blood by calculation

191

828

2.54

27.81

5.1

3.5

mmol/l

1.5

2.0

0.93

152

662

(3021447) Carbon dioxide [Partial pressure] in Venous blood

192

835

2.53

27.76

5.2

3.4

kpa

5.7

5.8

2.00

183

808

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

292

3.52

27.12

1.5

1.2

u/ml

10.0

5.2

0.79

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

288

3.53

26.98

1.5

1.2

u/ml

33.5

2.8

0.54

(3034274) Bile acid [Moles/volume] in Serum --fasting

116

5.10

26.71

3.1

2.2

umol/l

21.7

5.4

1.55

(3026493) Urate [Moles/volume] in Serum or Plasma

425

2603

1.96

25.88

3.9

2.5

umol/l

1831.8

5669.1

2.24

378

2269

(3009508) Creatinine [Moles/volume] in Urine

483

3111

1.90

25.10

3.9

3.1

mmol/l

7.0

7.5

1.55

417

2635

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

283

1516

2.12

24.88

2.1

1.8

—

(36660697) Celiac disease serology panel - Serum

187

846

2.42

24.69

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

311

3.30

24.54

1.5

1.2

u/ml

44.7

24.9

0.46

(3026008) Bacteria identified in Urine by Culture

467

3001

1.89

24.25

3.9

2.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

319

3.25

24.19

1.7

1.6

iu/ml

0.1

0.05

(3026782) Osmolality of Urine

329

1887

2.01

23.91

3.6

2.6

mosm/kgh2o

520.8

542.8

1.10

291

1609

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

105

5.02

23.58

1.2

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

113

4.85

23.53

2.3

2.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

281

1534

2.07

23.34

3.5

2.7

e6/l

2.7

2.6

0.04

168

808

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

210

3.73

23.33

1.6

1.9

nmol/l

1.0

0.8

1.28

176

(3012516) Albumin [Mass/volume] in Urine

449

2883

1.87

23.13

3.9

3.2

mg/l

176.6

330.0

0.60

303

1775

(3030905) Polymorphonuclear cells [#/volume] in Blood

189

3.86

22.94

5.0

3.3

e9/l

4.0

4.2

0.24

189

(3039162) Centromere protein B Ab [Units/volume] in Serum

133

4.44

22.68

1.6

1.3

u/ml

40.8

58.6

—

(3000991) Gas panel - Venous blood

168

754

2.42

22.48

9.6

8.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

372

2271

1.91

22.27

10.5

4.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

461

3021

1.83

22.00

4.7

3.9

mg/mmol

13.4

7.1

1.23

305

1854

(3030467) Casts [#/volume] in Urine by Automated count

422

2692

1.85

21.96

4.4

2.9

e6/l

0.3

0.4

0.79

333

1999

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1175

10407

3.00

21.83

31.5

12.8

mg/l

17.2

22.8

11.19

1055

8093

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

8.22

21.82

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

196

3.72

21.78

5.2

3.6

57.8

57.6

0.03

196

(40768804) Tissue Pathology biopsy report

595

4217

1.78

21.76

2.3

2.1

—

(3002582) Erythrocytes [#/volume] in Urine

452

2953

1.83

21.73

4.5

3.1

e6/l

40.5

76.5

0.74

367

2247

(36304419) Bacteria [Presence] in Urine

417

2658

1.85

21.71

4.3

2.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

9.79

21.49

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

883

7045

1.85

21.44

6.3

4.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

287

1629

1.99

21.17

3.4

2.6

e6/l

0.9

1.0

0.22

174

901

(46235355) HIV 1 and 2 tests - Meaningful Use set

308

1793

1.95

21.10

1.7

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

256

3.31

20.95

1.5

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

333

2025

1.88

19.82

3.4

2.5

e6/l

5.7

6.2

0.24

295

1785

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

8.78

19.82

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

163

763

2.31

19.72

1.6

3.1

g/l

69.1

67.1

1.85

149

703

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

8.28

19.68

1.1

1.2

—

(3018095) Leukocytes [#/volume] in Urine

505

3496

1.74

19.39

5.1

3.6

e6/l

79.0

85.9

0.10

383

2410

(3031040) Bacteria [#/volume] in Urine by Automated count

840

6705

1.76

19.16

6.0

4.2

e6/l

94.7

2463.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

362

2286

1.82

18.97

1.7

1.5

nmol/l

18.6

21.1

2.67

328

1945

(3015171) Extractable nuclear Ab [Units/volume] in Serum

105

408

2.72

18.87

1.6

1.2

u/ml

4.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

12.04

18.72

1.7

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

111

450

2.61

18.34

2.0

2.1

u/l

48.0

39.0

2.85

102

399

(3019309) Folate [Moles/volume] in Red Blood Cells

290

1726

1.88

18.27

2.0

1.7

nmol/l

1100.8

1199.0

1.05

234

1292

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

233

3.22

17.93

1.6

1.2

u/ml

43.9

48.8

0.13

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

202

1069

2.06

17.87

2.0

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

208

3.35

17.84

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

156

762

2.20

16.95

3.7

3.5

ng/l

85.4

80.9

0.26

143

676

(3009343) pH of Capillary blood

131

596

2.34

16.86

4.0

3.3

7.4

0.62

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

132

604

2.32

16.77

4.1

3.3

kpa

5.0

5.1

1.26

123

567

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

199

1078

2.01

16.43

2.0

1.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

138

656

2.24

16.00

1.5

2.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

125

573

2.31

15.79

4.1

3.3

mmol/l

0.9

1.9

1.75

432

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

437

3036

1.67

15.76

2.6

2.1

u/l

370.9

212.8

0.44

416

2862

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

7.30

15.71

3.1

2.9

u/ml

528.0

931.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

210

3.16

15.59

1.7

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

206

1151

1.94

15.50

2.1

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

11.56

15.33

1.1

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

4.60

15.24

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

4.60

15.24

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

4.60

15.24

1.3

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1175

10709

2.51

15.02

30.6

14.5

mmol/l

139.1

139.7

13.96

1159

10419

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

4.49

14.79

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

4.49

14.79

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

4.49

14.79

1.3

1.1

—

(3016502) Oxygen saturation in Arterial blood

176

948

2.00

14.68

8.9

8.5

95.5

95.8

0.26

170

915

(3011412) CD3 cells [#/volume] in Blood

4.35

14.61

1.4

2.0

e9/l

1.4

1.2

0.38

(3035350) Ketones [Presence] in Urine by Test strip

644

4993

1.59

14.52

4.5

3.6

estimate

0.0

0.00

129

927

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

305

2.70

14.37

2.2

2.3

199.5

181.5

1.09

291

(3023103) Potassium [Moles/volume] in Serum or Plasma

1175

10742

2.46

14.32

30.9

14.6

mmol/l

3.9

4.0

2.69

1160

10430

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

119

557

2.26

14.30

1.7

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

304

2.67

13.93

3.2

3.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

282

2.73

13.81

1.4

1.5

ug/g

266.2

306.6

0.87

165

(3000494) Fungus identified in Specimen by Culture

213

1249

1.85

13.72

1.9

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

190

1074

1.91

13.72

8.4

7.9

kpa

4.9

5.1

2.78

185

1026

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

5.18

13.67

1.4

1.6

—

(3017732) Neutrophils [#/volume] in Blood

137

692

2.10

13.59

2.3

2.9

e9/l

3.9

4.0

0.28

109

543

(3021601) Nitrite [Presence] in Urine by Test strip

641

5024

1.56

13.37

6.1

4.8

estimate

0.0

0.40

132

943

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

107

495

2.27

13.21

10.2

11.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

152

807

2.01

13.16

2.6

2.5

ml/min/173m2

68.3

68.4

0.01

325

(3009261) Glucose [Presence] in Urine by Test strip

645

5076

1.56

13.11

4.6

3.6

estimate

0.0

0.05

127

904

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

4.84

13.11

1.1

2.1

e9/l

0.2

0.27

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

284

2.67

13.09

3.1

2.8

u/ml

0.3

0.4

0.91

160

(3003396) Base excess in Arterial blood by calculation

187

1070

1.88

12.97

8.5

7.9

mmol/l

0.5

1.2

1.23

140

849

(3015377) Calcium [Moles/volume] in Serum or Plasma

470

3459

1.57

12.76

3.1

3.3

mmol/l

2.3

2.4

0.86

408

3025

(3024354) Oxygen [Partial pressure] in Venous blood

133

687

2.05

12.41

4.2

2.8

kpa

4.9

4.5

1.03

124

662

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

4.61

12.40

1.1

2.1

e6/l

566.3

586.7

0.04

(3004809) Band form neutrophils/100 leukocytes in Blood

148

3.26

12.28

3.0

3.4

1.2

0.00

121

(3014111) Lactate [Moles/volume] in Serum or Plasma

151

822

1.95

12.15

8.2

7.1

mmol/l

1.7

1.3

3.00

145

787

(3022313) Gas panel - Capillary blood

441

2.27

12.05

4.3

3.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

4.13

11.89

1.2

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

7.01

11.87

1.4

1.2

—

(4281824)

100

3.68

11.39

1.3

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

258

2.60

11.23

2.8

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

4.32

11.05

1.4

1.9

9.3

11.7

0.67

(3004616) Nuclear Ab [Presence] in Serum

127

3.30

11.02

1.4

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

332

2321

1.59

10.94

4.2

3.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.36

10.80

1.6

1.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

144

803

1.90

10.75

4.2

3.4

mmol/l

1.2

1.11

134

687

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

284

2.47

10.58

2.2

mg/l

11.6

11.5

0.03

259

(3019225) pH of Specimen

169

998

1.80

10.51

6.6

3.9

—

(3003181) Sodium [Moles/volume] in Urine

165

2.92

10.26

1.2

1.3

mmol/l

54.6

62.0

0.73

145

(3025941) Bacteria identified in Stool by Culture

108

556

2.03

10.16

1.6

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

236

2.57

10.05

2.4

2.8

mmol/l

24.0

25.1

1.11

210

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

329

2337

1.55

9.98

2.0

1.7

mg/l

1.7

1.0

3.20

264

1769

(3042111) Morphology [Interpretation] in Bone marrow Narrative

153

2.94

9.77

2.0

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

130

727

1.88

9.61

2.7

2.9

ng/l

153.1

165.1

0.18

121

659

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

491

2.06

9.56

10.8

9.8

mmol/l

24.1

24.5

0.52

461

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

4.55

9.32

2.5

3.0

u/ml

2820.2

1053.1

0.64

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

7.07

9.30

1.1

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

193

2.66

9.17

1.6

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

298

2107

1.54

9.13

1.7

1.6

pmol/l

52632042.1

20917329.7

0.38

247

1745

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.46

9.10

1.4

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.46

9.10

1.4

1.2

—

(3037121) Protein [Mass/volume] in Urine

345

2.22

9.00

3.3

3.4

g/l

0.3

0.22

131

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

367

2719

1.49

8.99

2.8

2.9

ng/l

1767.2

1049.4

0.98

307

2265

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

379

2.16

8.96

5.0

3.6

mmol/l

24.0

25.0

2.04

358

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

18.75

8.94

1.0

—

(3036489) Thrombin time

402

2.11

8.80

2.1

2.0

22.6

21.0

2.70

357

(3047181) Lactate [Moles/volume] in Blood

297

2.29

8.74

6.1

8.1

mmol/l

1.4

1.3

0.42

266

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

125

3.02

8.67

1.5

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

200

2.56

8.56

2.4

2.1

g/l

126.1

131.2

0.66

149

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1082

9928

1.65

8.51

26.8

11.8

ml/min/173m2

82.8

82.5

0.17

961

8138

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

367

2.14

8.49

2.5

2.0

ug/l

1.2

1.8

0.31

326

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

8.53

8.47

1.2

2.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1055

9628

1.60

8.41

5.5

4.8

mu/l

1.9

2.0

0.30

994

8847

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

104

566

1.91

8.35

1.6

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

124

2.96

8.17

1.5

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.79

8.13

1.7

2.2

umol/l

63.3

117.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

287

2.26

8.12

1.6

4.1

mg/l

37.4

38.2

0.03

240

(3034860) Kappa light chains.free [Mass/volume] in Serum

287

2.26

8.12

1.6

4.1

mg/l

43.7

63.9

0.45

240

(3017354) Segmented neutrophils/100 leukocytes in Blood

3.28

8.10

3.1

3.4

58.9

53.6

0.50

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

131

2.88

8.00

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

265

1874

1.52

8.00

3.6

ng/l

170.4

410.7

2.26

201

1392

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

121

2.95

7.90

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

121

2.95

7.90

1.5

1.4

—

(1616796) Gas panel - Central venous blood

178

2.58

7.89

5.5

3.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

185

2.54

7.81

1.3

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

376

2864

1.45

7.81

1.9

1.7

mmol/l

1.5

1.4

1.34

336

2415

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

915

8146

1.45

7.81

4.4

4.1

pmol/l

14.8

14.7

0.44

856

7444

(3005988) Vibrio sp identified in Specimen by Organism specific culture

122

2.92

7.79

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

122

2.92

7.79

1.5

1.4

—

(3044927) Protein electrophoresis panel - Urine

101

3.12

7.74

1.3

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

117

2.96

7.74

1.1

1.2

—

(3021901) Oxygen saturation in Capillary blood

168

2.61

7.74

2.5

—

(3002385) Erythrocyte distribution width [Ratio]

972

8772

1.48

7.57

37.8

15.8

14.2

13.6

17.63

964

8572

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1183

11196

1.97

7.52

30.3

9.8

u/l

42.4

26.0

47.59

1172

10813

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

3.70

7.48

2.5

1.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

470

3753

1.40

7.42

4.2

3.3

ng/l

36.1

46.6

0.42

344

2496

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

292

2.18

7.40

2.7

—

(3045414) Leukocytes [Presence] in Urine

458

1.92

7.06

2.3

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

262

1899

1.48

6.93

1.3

iu/ml

38.8

31.5

0.46

606

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

280

2.16

6.92

1.6

4.1

ratio

1.0

1.3

—

(3002256) Pathology report gross observation

194

1326

1.55

6.77

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

155

1007

1.62

6.72

3.9

2.9

—

(3009871) Measles virus Ab [Titer] in Serum

5.05

6.71

1.8

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

3.08

6.64

1.3

1.1

u/ml

54.2

24.3

—

(3019060) Gas panel - Arterial blood

105

618

1.76

6.59

5.0

5.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

165

2.47

6.48

2.0

1.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

196

2.34

6.48

1.1

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

196

2.34

6.48

1.1

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1042

9627

1.48

6.36

8.2

5.4

mmol/mol

41.3

39.4

6.31

992

8955

(3037756) Immunofixation for Serum or Plasma

217

2.26

6.36

1.3

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

333

2.00

6.26

2.0

1.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

341

1.99

6.21

1.5

2.7

g/l

3.1

0.01

276

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

363

1.95

6.17

1.6

2.6

g/l

4.1

3.6

1.97

270

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

363

1.95

6.17

1.6

2.6

g/l

7.7

7.3

0.61

283

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

363

1.95

6.17

1.6

2.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

363

1.95

6.17

2.2

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

472

3859

1.36

6.15

4.8

3.7

—

(3036048) Francisella tularensis Ab [Titer] in Serum

5.83

6.11

1.2

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

587

1.75

6.07

7.2

7.7

mmol/l

23.3

24.6

2.29

547

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

337

1.98

6.07

1.7

2.7

g/l

14.8

10.2

4.54

295

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

232

2.16

5.83

2.0

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.68

5.74

1.2

2.1

—

(40767503) Oxygen content in Capillary blood by calculation

188

2.28

5.72

3.1

2.4

16.8

16.3

0.30

(3012501) Base excess in Blood by calculation

188

2.28

5.72

6.4

3.2

mmol/l

3.2

2.6

0.69

125

(40760888) Immunoglobulin light chains.free panel - Serum

214

2.19

5.72

1.5

4.4

—

(40768443) Skin Pathology biopsy report

439

1.83

5.70

1.1

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

763

6749

1.33

5.65

3.1

3.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

104

2.73

5.62

2.3

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.96

5.59

1.3

—

(21494434) Karyotype in Bone marrow

2.83

5.59

1.2

1.3

—

(3028433) Virus identified in Specimen by Culture

4.28

5.56

1.2

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.93

5.48

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

2.85

5.43

1.4

mmol/l

15.1

11.0

1.13

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

243

1813

1.42

5.42

1.3

u/ml

14.0

11.1

0.23

716

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

226

2.12

5.40

2.0

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.76

5.37

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.76

5.37

1.3

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.95

5.32

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

2.95

5.32

2.0

1.4

promille

1.1

1.2

0.11

(1761868) Lipid panel - Serum or Plasma

309

3876

0.73

5.31

3.4

2.7

—

(3013512) EKG study

363

2915

1.34

5.14

4.2

3.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.78

5.10

1.2

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

287

1.96

5.08

1.6

2.7

g/l

37.8

38.4

0.27

255

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

160

2.29

5.02

1.2

1.4

—

(21494755) Public health laboratory ask at order entry panel

1057

0.56

4.88

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

345

2770

1.34

4.85

4.0

3.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

278

1.95

4.84

1.6

2.8

g/l

0.0

0.50

260

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

119

2.47

4.82

1.2

1.4

pmol/l

282.8

322.4

0.31

(3029937) Albumin [Presence] in Urine by Test strip

332

2665

1.33

4.65

5.0

3.9

estimate

0.0

0.04

132

918

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1066

10030

1.42

4.62

4.9

3.9

mmol/l

1.4

1.3

3.57

1001

9235

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

305

1.88

4.59

1.6

3.0

g/l

0.7

1.1

0.36

277

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2.56

4.48

1.7

2.4

33.7

32.4

0.92

(3010421) pH of Blood

232

1.97

4.34

6.2

3.1

7.4

0.18

186

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

694

0.49

4.33

1.6

1.4

—

(3045424) Erythrocytes [Presence] in Urine

171

2.14

4.32

1.8

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1077

10178

1.41

4.31

5.9

4.4

mmol/l

6.2

5.9

9.49

1011

9305

(3003694) ABO and Rh group [Type] in Blood

352

2877

1.31

4.30

1.5

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

207

2.01

4.20

1.4

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1102

10466

1.43

4.19

5.6

4.3

mmol/l

4.6

4.7

6.55

1043

9733

(21494814) CD8 cells/100 lymphocytes in Specimen

3.78

4.09

1.9

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

8.04

4.06

1.3

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

136

2.24

4.04

2.2

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

156

2.15

4.02

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

2.62

3.98

1.4

2.0

e6/l

639.3

690.2

0.11

(3019150) Specific gravity of Urine by Refractometry

276

2203

1.32

3.96

4.8

3.9

kg/l

1.0

0.08

316

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

179

2.04

3.87

1.8

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.79

3.86

1.1

1.2

—

(3017704) Immunofixation for Urine

2.99

3.85

1.4

1.9

—

(3014271) Vancomycin [Susceptibility]

3.09

3.81

4.4

2.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.82

3.81

1.2

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

8.79

3.77

1.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

108

2.34

3.77

2.6

4.0

—

(40768446) Kidney Pathology biopsy report

3.55

3.77

1.6

—

(3020491) Glucose [Moles/volume] in Blood

2.59

3.73

2.2

1.7

mmol/l

7.8

6.7

0.77

(3022621) pH of Urine by Test strip

661

1.52

3.67

3.7

2.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

2.56

3.64

1.4

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

999

0.61

3.62

1.6

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

113

794

1.47

3.48

2.0

2.3

ug/l

5.7

7.4

0.77

101

702

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.36

3.48

1.2

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1091

10406

1.37

3.48

5.5

4.3

mmol/l

1.4

1.5

8.06

1027

9631

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.91

3.47

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

313

1.72

3.40

1.3

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.59

3.39

2.6

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

261

1.79

3.38

1.4

1.3

mg/l

575.7

514.0

0.18

247

(3014051) Protein [Presence] in Urine by Test strip

239

1.83

3.38

2.7

2.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

230

1828

1.32

3.37

2.8

2.9

mmol/l

2.5

2.4

1.35

199

1598

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.12

3.37

1.0

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.12

3.37

1.2

1.0

miu/ml

1742.1

1717.2

0.02

(3024891) Influenza virus A+B Ag [Presence] in Specimen

277

1.76

3.34

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.94

3.30

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1111

10645

1.38

3.28

6.0

4.8

mmol/l

2.7

2.8

5.38

1043

9849

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

309

1.71

3.28

1.3

1.1

—

(3042631) Mycobacterium sp identified in Specimen

122

2.16

3.27

4.4

2.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

317

1.70

3.26

1.3

1.2

—

(4146454)

103

2.26

3.23

2.6

2.5

—

(3029075) Extractable nuclear Ab panel - Serum

3.18

3.22

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

319

1.69

3.20

1.3

miu/ml

244.5

235.4

0.06

148

(3003327) Ova and parasites identified in Stool by Light microscopy

359

1.65

3.15

1.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.97

3.14

1.5

2.3

ug/l

65.9

62.1

0.08

(3045142) Bone marrow Pathology biopsy report

118

2.14

3.11

1.2

1.4

—

(3036603) Volume of Urine

2.45

3.05

1.7

1.5

2043.8

1789.5

—

(4024509)

2.28

3.04

1.6

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.91

3.03

1.8

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.91

3.03

1.8

2.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

5.86

3.02

1.3

1.1

—

(3003129) Base excess in Capillary blood by calculation

4.31

2.99

1.3

1.4

mmol/l

-1.2

1.9

—

(3051611) Lipemic interference index of Serum or Plasma

107

2.17

2.98

4.3

3.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

167

1294

1.34

2.92

5.4

4.3

31.2

32.0

0.39

135

866

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.85

2.92

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

102

2.18

2.88

1.3

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

6.69

2.87

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

6.69

2.87

1.0

—

(3017569) Oxygen content in Arterial blood

2.95

2.86

2.2

3.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

109

2.13

2.85

1.1

—

(40768795) Lymph node Pathology biopsy report

103

2.16

2.81

1.5

1.1

—

(3049717) Cytology report of Urine Cyto stain

339

1.62

2.81

2.1

2.6

—

(3012441) Differential panel - Pleural fluid

2.41

2.80

1.2

1.4

—

(40761536) Microorganisms panel - Urine sediment

117

863

1.39

2.80

4.9

3.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

1019

9696

1.27

2.79

32.4

13.8

39.1

40.0

2.44

747

7105

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

2.18

2.78

1.6

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

652

1.44

2.76

2.4

2.2

nmol/l

13.2

12.9

0.09

580

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

8.36

2.75

1.0

1.2

—

(3000330) Specific gravity of Urine by Test strip

488

1.50

2.70

4.8

3.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.23

2.68

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.19

2.68

1.3

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

243

1.71

2.66

2.2

2.4

ug/min

116.1

83.4

0.33

141

(3013139) Helicobacter pylori Ag [Presence] in Stool

717

1.41

2.64

1.3

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.41

2.64

1.6

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

7.17

2.55

1.0

1.1

—

(40761511) CBC panel - Blood by Automated count

1134

10969

1.35

2.55

27.5

11.9

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.48

2.54

1.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.18

2.51

1.6

2.5

—

(3021788) Differential panel - Synovial fluid

180

1.80

2.49

1.4

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

102

2.08

2.48

1.3

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

283

0.42

2.47

1.8

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

109

2.04

2.47

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.96

2.41

1.2

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.35

2.39

1.2

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.52

2.36

1.1

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

324

1.57

2.33

4.3

3.9

mmol/l

1.4

1.3

0.64

318

(3045788) Cell count panel - Pleural fluid

2.32

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.08

2.27

3.7

2.1

—

(3052592) Norovirus Ag [Presence] in Stool

4.63

2.27

1.2

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

113

1.96

2.26

1.9

1.5

—

(3000492) Spirometry study

133

1040

1.31

2.22

1.6

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

181

1.73

2.16

4.2

2.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

555

1.41

2.16

1.4

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.51

2.05

1.0

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

224

1885

1.23

2.05

1.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

3.09

2.01

5.0

6.0

mmol/l

22.8

25.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

224

1.63

2.01

1.6

1.4

e6/l

12606.1

986.4

0.47

185

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

224

1.63

2.01

1.4

e6/l

47.4

13.6

0.72

179

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.64

2.01

1.1

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

104

1.94

2.01

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.16

1.98

1.1

—

(44790048)

119

1.86

1.98

1.5

1.6

—

(44790047)

119

1.86

1.98

1.5

1.6

—

(44790049)

119

1.86

1.98

1.5

1.6

—

(44806118)

119

1.86

1.98

1.5

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

201

0.44

1.97

1.2

1.4

—

(3042517) Benzodiazepines panel - Urine

4.56

1.94

2.0

2.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.56

1.94

1.2

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.97

1.93

2.4

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

1.70

1.88

2.2

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

587

0.65

1.88

1.8

1.7

—

(3051651) Icteric interference index of Serum or Plasma

2.10

1.86

4.7

3.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

129

1.80

1.86

2.3

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.87

1.86

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

428

0.60

1.85

1.7

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.22

1.84

1.2

1.1

ratio

1.1

—

(3020891) Body temperature

360

1.46

1.84

5.4

4.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

556

1.37

1.82

1.1

1.0

—

(40761535) Cells panel - Urine sediment

102

798

1.30

1.74

4.4

3.3

—

(3005033) Fetal Nuchal fold Thickness US

193

0.46

1.73

1.2

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

194

0.46

1.73

1.2

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.86

1.71

1.2

—

(3016330) Potassium [Moles/time] in 24 hour Urine

3.86

1.71

1.2

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.07

1.70

1.4

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

503

1.37

1.69

2.6

2.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

142

1.70

1.65

1.1

1.0

u/ml

4.4

1.8

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

113

1.78

1.61

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.34

1.60

1.3

2.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

236

0.50

1.60

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

236

0.50

1.60

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

236

0.50

1.60

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

235

0.51

1.58

1.2

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

129

1.72

1.57

1.0

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.21

1.57

1.0

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

315

1.44

1.54

2.3

2.1

u/l

10941.7

2768.3

0.56

128

(3044889) 12 lead EKG panel

774

7337

1.14

1.52

3.9

3.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.34

1.52

1.4

2.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.60

1.51

1.0

1.3

—

(3024928) Oxygen saturation in Venous blood

194

1.56

1.49

2.8

3.3

—

(3008898) HLA-B27 [Presence]

411

1.38

1.49

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

255

0.54

1.48

1.3

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

269

1.46

1.45

1.5

1.3

u/l

9.5

10.3

0.18

213

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

152

0.46

1.44

1.4

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.74

1.43

1.8

1.3

—

(3007461) Platelets [#/volume] in Blood

1191

11713

1.32

1.42

45.6

18.9

e9/l

234.9

254.9

15.82

1179

11429

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.18

1.40

4.7

3.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

264

1.45

1.38

1.5

1.7

nmol/l

53.8

38.8

1.24

252

(3024731) MCV [Entitic volume]

1191

11719

1.31

1.36

45.2

18.8

91.8

90.9

7.95

1182

11554

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.95

1.36

2.0

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.15

1.33

1.1

1.0

—

(3010813) Leukocytes [#/volume] in Blood

1191

11722

1.31

1.33

45.5

18.9

e9/l

6.5

6.6

1.43

1176

11406

(4268621)

113

1.69

1.32

2.4

2.3

—

(3023419) Bacteria identified in Sputum by Culture

121

1.66

1.31

6.7

2.9

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.51

1.30

1.5

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.51

1.30

1.0

1.1

99.7

100.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.51

1.30

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.51

1.30

1.2

1.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

1191

11725

1.30

45.7

19.0

g/l

133.2

135.7

6.49

1182

11560

(40765096) Chromosome analysis panel by Banding

2.36

1.29

1.3

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.36

1.29

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.78

1.28

1.0

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.09

1.28

1.8

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.09

1.28

1.8

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.09

1.28

1.8

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.09

1.28

1.8

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.29

1.27

8.3

4.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

287

1.41

1.24

1.2

—

(3011648) Oxygen content in Venous blood

1.87

1.24

2.4

3.7

7.9

11.0

1.94

(3035941) MCH [Entitic mass]

1190

11720

1.29

1.24

45.2

18.8

30.5

30.3

4.18

1181

11553

(3026361) Erythrocytes [#/volume] in Blood

1190

11721

1.29

1.23

45.4

18.9

e12/l

4.4

4.5

8.24

1175

11403

(3044941) Cell count panel - Synovial fluid

156

1.55

1.20

1.5

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

117

1.63

1.18

1.1

—

(3024263) Appearance of Synovial fluid

2.01

1.16

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

102

1.68

1.16

1.2

2.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

1.2

—

35.7

—

(3032057) Clostridioides difficile [Presence] in Stool

2.51

1.15

2.0

1.9

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

118

1.62

1.15

1.2

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

388

1.33

1.13

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

674

1.25

1.12

1.3

1.2

u/ml

153.0

222.8

0.63

619

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.26

1.10

1.1

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.26

1.10

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

144

1.54

1.09

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.96

1.09

3.5

2.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.19

1.08

1.1

1.2

—

(4198724)

2.19

1.08

3.9

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

279

1.37

1.06

1.1

—

(3025130) Human papilloma virus identified in Specimen

137

1.54

1.06

2.0

1.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

129

1.56

1.06

1.6

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.28

1.03

4.0

7.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.28

1.03

1.6

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.28

1.03

2.0

3.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.28

1.03

4.8

7.8

—

(3016750) Collection duration of Urine

1.84

1.03

1.9

2.2

min

498.8

503.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.06

1.03

2.0

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

171

1.47

1.02

1.4

1.2

u/ml

1.6

4.1

0.79

(3044242) Glucose [Moles/volume] in Arterial blood

1.92

1.02

3.1

3.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.18

0.98

1.4

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.86

0.96

1.3

1.1

—

(40768806) Pleura Pathology biopsy report

1.70

0.95

1.5

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.77

0.94

3.8

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.77

0.94

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.90

0.94

4.1

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.90

0.94

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.90

0.94

1.9

—

(3008295) Osmolality of Serum or Plasma

109

1.57

0.93

1.5

1.4

mosm/kgh2o

283.3

278.1

0.34

(3000475) Leukocytes [#/volume] in Synovial fluid

243

1.37

0.93

1.6

1.7

e6/l

14776.7

14654.4

0.01

188

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.74

0.92

3.8

1.4

—

(3012565) Volume of 24 hour Urine

1.82

0.92

1.3

2.7

2359.0

1909.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.15

0.91

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.15

0.91

1.2

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.07

0.89

7.2

3.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.07

0.89

1.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.07

0.89

7.2

3.2

—

(3035880) pH of Pleural fluid

1.91

0.88

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.62

0.87

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.62

0.87

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.62

0.87

1.6

—

(3004451) EKG impression Narrative

1.87

0.87

1.1

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.00

0.87

1.0

1.1

—

(3034426) Prothrombin time (PT)

1.94

0.84

1.5

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

178

0.61

0.83

1.5

1.6

—

(3047189) Immunofixation for 24 hour Urine

1.74

0.82

1.0

1.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

284

1.31

0.82

1.4

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.58

0.81

1.3

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.79

0.0

1.8

—

(3005570) Glucose [Moles/volume] in Urine

106

1.52

0.79

1.6

2.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.78

0.0

1.0

—

31.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

124

1.46

0.75

2.6

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

245

1.31

0.74

7.3

4.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

924

0.85

0.74

1.5

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

138

1227

1.14

0.74

8.7

6.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.85

0.73

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.67

0.72

1.1

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

170

0.64

0.71

1.2

1.1

u/ml

0.4

2.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.56

0.70

3.8

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

686

1.18

0.69

2.6

3.4

pmol/l

4.4

4.6

0.92

601

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

275

1.28

0.68

1.4

—

(4015189)

1.86

0.68

1.4

2.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

215

0.69

0.68

4.6

3.7

u/ml

20.8

33.5

1.15

210

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

133

1485

0.88

0.68

2.5

2.9

ug/l

0.7

0.8

0.26

947

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

103

1.46

0.65

1.2

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

201

0.69

0.64

1.8

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

146

1.38

0.64

2.5

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.52

0.62

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

104

1.45

0.62

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

173

1.34

0.62

1.5

1.2

u/ml

5.4

5.3

0.01

(4211845)

1.57

0.60

5.1

2.6

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.00

0.60

0.0

2.7

—

4071.2

—

(3006653) Thiamine [Moles/volume] in Blood

1.54

0.59

1.0

1.2

nmol/l

115.8

150.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

455

1.20

0.59

1.4

1.3

iu/l

34.4

30.0

0.33

381

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.51

0.58

1.0

1.3

—

90.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

175

1.32

0.58

4.0

3.0

nmol/l

0.8

0.08

140

(3036071) Salmonella sp Ab [Titer] in Serum

1.72

0.57

1.0

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

267

1.24

0.54

1.4

1.5

pmol/l

125.9

222.9

0.77

262

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.54

0.53

1.2

123.3

109.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

170

1.30

0.51

1.4

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

153

1.31

0.50

1.6

1.4

mmol/l

7.9

7.5

0.16

105

(3006462) Nitrate [Presence] in Urine

1.56

0.49

4.1

2.8

—

(3000012) Reticulocyte production index

1.56

0.49

1.1

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

102

1.38

0.47

3.1

3.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

189

2025

0.92

0.47

3.7

4.0

22.0

21.3

0.22

925

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

104

1143

0.90

0.44

1.6

2.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

229

1.23

0.44

1.8

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.36

0.41

1.4

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

287

1.19

0.40

1.4

2.0

iu/l

3.1

4.9

—

104

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

105

0.66

0.39

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

214

0.79

0.38

3.4

3.5

mg/l

43.4

21.2

1.22

132

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

147

0.75

0.37

1.5

1.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.31

0.37

1.1

1.5

ug/l

4.3

8.5

—

(4010399)

745

1.11

0.37

1.5

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

180

1.23

0.36

1.1

—

10.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

424

1.14

0.34

1.6

1.7

mg/l

4.5

4.3

0.04

305

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

377

1.15

0.34

2.4

1.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

771

1.10

0.32

1.2

iu/ml

174.8

138.7

0.35

316

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

106

985

1.08

0.31

1.3

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.73

0.31

1.1

—

(3027944) Amphetamines [Presence] in Urine

382

1.13

0.29

1.8

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

152

0.79

0.29

1.0

u/ml

0.1

3.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

606

0.90

0.28

1.7

1.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.23

0.27

1.8

1.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.23

0.27

2.9

1.9

—

(4034850)

328

1.13

0.27

8.9

—

(3000764) Benzodiazepines [Presence] in Urine

386

1.12

0.26

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

194

1856

1.05

0.26

1.5

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

123

1.22

0.25

1.1

1.2

nmol/l

—

(3027008) Opiates [Presence] in Urine

387

1.12

0.25

1.7

—

(3028300) Cannabinoids [Presence] in Urine

388

1.11

0.24

1.9

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

1.28

0.23

3.6

11.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.16

0.21

1.2

2.2

ug/l

28.1

202.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

177

0.85

0.21

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

6.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

164

1.16

0.20

2.5

2.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.20

0.0

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.25

0.20

1.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

176

0.85

0.20

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

479

0.92

0.20

1.6

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

175

0.86

0.19

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

143

0.84

0.18

1.0

u/ml

0.0

1.5

—

(3015183) Erythrocyte sedimentation rate

1.19

0.18

1.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

383

0.91

0.18

1.3

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

173

0.87

0.16

2.5

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

258

2515

1.03

0.16

4.4

4.6

ug/l

1.8

2.3

1.15

235

2277

(44813793)

1.10

0.15

1.1

1.0

—

(3011288) Drugs identified in Urine by Screen method

265

1.10

0.14

1.6

2.3

—

(4306422)

169

1.13

0.14

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

122

1.15

0.13

1.1

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

393

1.07

0.13

1.5

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

161

1.12

0.13

1.1

—

(3016879) Cocaine [Presence] in Urine

356

1.07

0.12

1.8

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

162

1.11

0.12

1.2

—

(40768800) Prostate Pathology biopsy report

157

0.89

0.11

1.1

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.77

0.08

1.4

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.87

0.07

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

104

0.86

0.06

1.6

1.4

ug/l

5.4

2.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

118

1199

0.98

0.05

1.6

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

101

1022

0.99

0.02

1.6

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

104

1.06

0.01

7.7

2.4

—

(3023410) Appearance of Cerebral spinal fluid

114

1.05

0.00

1.2

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

156

0.96

0.00

3.9

5.3

umol/l

363.0

363.2

0.00

140

(40768793) Breast Pathology biopsy report

296

1.01

0.00

1.3

—

(4094501)

288

1.01

0.00

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

298

1.01

0.00

2.0

1.7

—

(1002224) Polysomnography panel

472

1.00

0.00

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

157

1.02

0.00

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(4027681)

0.94

0.00

1.5

1.2

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

190.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.97

0.00

4.5

6.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013466) aPTT in Blood by Coagulation assay

0.00

0.0

1.0

—

33.9

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

5.5

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

9.9

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

39.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.0

—

(4038314)

0.00

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.5

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_CHRONHEP and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_CHRONHEP	2.604 [2.3, 2.95]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.142

During the follow-up period (1.1.1998 — 31.12.2019), 918 out of 3652 females with K11_CHRONHEP died.

Males

Parameter	HR [95% CI]	p-value
K11_CHRONHEP	3.327 [2.86, 3.87]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.022

During the follow-up period (1.1.1998 — 31.12.2019), 739 out of 2256 males with K11_CHRONHEP died.

Mortality risk

Mortality risk for people of age

years, who have K11_CHRONHEP.

N-year risk	Females	Males
1	0.215%	0.576%
5	1.371%	4.121%
10	3.587%	9.979%
15	6.769%	19.304%
20	12.043%	30.726%

Relationships between endpoints

↥

Index endpoint: K11_CHRONHEP – Chronic hepatitis, not elsewhere classified

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Chronic hepatitis, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints